The global branched-chain amino acid market size is estimated to witness a CAGR of 13.2% from 2021 to 2026. Increasing incidences of various health disorders are key driving factors for the BCCA market to grow eventually.
An amino acid with a branch of the aliphatic side chain is known as a branched-chain amino acid. The branched-chain amino acid plays a vital role in the management of obesity by oxidation of fatty acid. Also, the metabolism of this compound will maintain immune systems and look over the brain's functionalities. These are highly essential for humans as nearly 35% of the amino acids are used in muscle proteins, whereas, for animals, it is 40%. In general, amino acids are oxidized in the liver, while branched-chain amino acids will look after the skeletal muscles and peripheral tissues.
MARKET DRIVERS:
The rise in the concern towards health by taking dietary supplements in the regular diet is accelerating the growth of the market. Growing demand to improve the quality of the drugs in pharmaceutical industries is propelling the branched-chain amino acid market.
The adoption of advanced technology and the launch of innovative equipment favoring the industries set up growth opportunities for the market. Increasing support from the government in changing policies and introducing reimbursement schemes greatly influences the branched-chain amino acid market. The rise in the need for targeted therapies is lavishing the growth of the market.
MARKET RESTRAINTS:
However, rapid changes in the economic strategies are to impede the demand of the branched-chain amino acids market. Fluctuations in the availability of the raw materials are proportionally increasing the final products' prices, which remained a challenging factor for the market developers.
Impact of COVID-19 on the global branched-chain amino acids market:
COVID-19 is a global public health issue that has affected almost every industry. COVID-19 is a virus that infects people. Depending on the timing of the outbreak and consumer behavior, the impact of the pandemic on the global branched-chain amino acids (BCAAs) market differed significantly by country and end-user usage. Since BCAAs, unlike other amino acids, cannot be produced by the body, they are considered necessary. Leucine, isoleucine, and valine are the three basic amino acids that form branched-chain amino acids.
BCAA supplements are widely used to promote muscle development and improve exercise performance. They can also help people lose weight and reduce post-exercise exhaustion. The BCAA Supplements industry will continue to be a relatively high-energy industry in the coming years. The increased competition has forced BCAA supplement producers to adjust their prices to remain competitive. The global nutritional supplement market has seen a significant increase, which has affected the growth of the BCAA supplement market. On the other hand, people worldwide are being driven to keep their physical health in check, which is growing the BCAA supplement market. Overall, coronavirus had a moderate effect on global BCAAs in 2020, with a major recovery forecast in coming years.
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2021 to 2026 |
|
Base Year |
2020 |
|
Forecast Period |
2021 to 2026 |
|
Forecast Units |
Millions (USD) |
|
Segments Analysed |
By Type, Application, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Analysed |
North America (the United States and Canada), Europe (UK, Spain, Germany, Italy, France and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, New Zealand, Rest of APAC), Latin America (Brazil, Argentina, Mexico and Rest of Latin America), Middle East and Africa |
This research report on the global branched-chain amino acids (BCAA) market has been segmented & sub-segmented into the following categories and analyzed market size & forecast to 2026.
Branched-Chain Amino Acids (BCAA) Market – By Type:
Based on product type, the L-Valine segment is leading the market. Rising awareness over the utilization of chemical compounds appropriately for human life's well-being is leveraging the growth rate of this segment.
Branched-Chain Amino Acids (BCAA) Market – By Application:
Based on the application, the Animal feed segment is holding the highest shares of the market. Increasing care over the health of the animals, especially dogs, cats, and other pet animals, is ascribed to bolster the demand of the market.
Branched-Chain Amino Acids (BCAA) Market – By Region:
Geographically, North American BCCA Market accounts for dominant shares globally by launching innovative products with high-performance levels. Also, increasing capital income in both developed and developing countries is likely to outshine the market demand in this region.
European BCCA Market is positioned next to North America to lead the shares with the rise in the funds from private and public organizations over pharmaceutical industries. Growing demand from the food and beverage industry to improve their products' sales is leveraging the branched-chain amino acid market's growth.
Asia Pacific BCCA Market has a tremendous growth rate from the past decade and will hit the CAGR of 14.7% during the review period. Rising expenditure on healthcare, especially in the urban areas, is magnifying the growth of the Branched-Chain Amino Acids Market.
KEY MARKET PARTICIPANTS:
A few of the noteworthy companies operating in the global branched-chain amino acids market profiled in this report are Ajinomoto Co., Inc, Amino GmbH, Anhui Huaheng Biotechnology Co., Ltd, CJ Bio America, Daesang Corporation, Evonik Corporation, Fufeng Group Company Limited, Fuyang Dongchen Biological Engineering Co., Ltd., Henan Julong Bio-Engineering Co., Ltd, Iris Biotech GmbH, Kyowa Hakko Bio Co., Ltd., And Meihua Holdings Group Co., Ltd.
